Application 209017
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | 17GM/SCOOPFUL | No | No |
| 002 | POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | 17GM/PACKET | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209017-001 | POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | ||
| A209017-002 | POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | 17GM/PACKET | FOR SOLUTION / ORAL | 2024-04-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209017-001 | POLYETHYLENE GLYCOL 3350 | 17GM/SCOOPFUL | FOR SOLUTION / ORAL | 2018-04-09 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209017-002 | POLYETHYLENE GLYCOL 3350 | 17GM/PACKET | FOR SOLUTION / ORAL | 2024-04-23 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 365 WHOLE FOODS MARKET Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Whole Foods Market, Inc. | b19f42a9-18ac-4d23-87b5-3c43e47c4054 | 2026-06-05 | Warnings | 209017 ANDA209017 |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | CARDINAL HEALTH 110, LLC. DBA LEADER | 04cc4f2e-1725-4710-8cfb-73a6bdf52e4f | 2026-04-23 | Warnings | 209017 ANDA209017 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurobindo Pharma Limited | b51f2223-8266-4d6c-bf32-58e53e73b54d | 2026-04-23 | Warnings | 209017 ANDA209017 |
| COMFORTLAX | POLYETHYLENE GLYCOL 3350 | Family Dollar Stores, LLC | 02a44a41-0039-f6ec-e063-6394a90ae6f1 | 2026-04-23 | Warnings | 209017 ANDA209017 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurohealth LLC | d3c77f3f-57aa-4e2d-88aa-731cbb22af70 | 2026-04-23 | Warnings | 209017 ANDA209017 58602-805 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58602-805 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 | Aurohealth LLC | ANDA | Current |
| 58602-805 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 | Aurohealth LLC | ANDA | Current |
| 58602-805 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 | Aurohealth LLC | ANDA | Current |
| 58602-805 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 | Aurohealth LLC | ANDA | Current |